ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions

Lucie Bruijn(Ludwig Cancer Research), Mark W. Bêcher(Johns Hopkins University), Michael K. Lee(Johns Hopkins University), Kenton L. Anderson(Ludwig Cancer Research), N.A. Jenkins(National Cancer Institute), Neal G. Copeland(National Cancer Institute), Sangram S. Sisodia(Johns Hopkins University), Jeffrey D. Rothstein(Johns Hopkins University), David Borchelt(Johns Hopkins University), Donald L. Price(Johns Hopkins University), Don W. Cleveland(Ludwig Cancer Research)
Neuron
February 1, 1997
10.1016/s0896-6273(00)80272-x
Cited by 1,328Open Access
Full Text

Abstract

Related Papers

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
Barry Halliwell|The Lancet|1994|2.9k
Localization of neuronal and glial glutamate transporters
Jeffrey D. Rothstein, Lee J. Martin, Allan I. Levey et al.|Neuron|1994|1.7k
An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
Philip C. Wong, Carlos A. Pardo, David Borchelt et al.|Neuron|1995|1.4k
Cloning and expression of a rat brain L-glutamate transporter
Gilia Pines, Niels C. Danbolt, Magnar Bjørås et al.|Nature|1992|1.2k
Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain.
Thorsten Storck, S. Schulte, Kay Hofmann et al.|Proceedings of the National Academy of Sciences|1992|1.2k